By Lila Taylor¹, Dr. Zhiqing Huang²

^{1 2}Duke University

Synopsis

This study investigates how aging effects the growth of ovarian cancer, as well as sensitivity of different ovariancancers to various chemotherapies. By growing and aging non-cancerous cells to mimic the environmentovarian cancer would see inside the human body, we were able to find that in the lab, ovarian cancer cellsgrew worse in the “older” condition compared to the “young” environment. Additionally, we identified achemotherapy called ibrutinib that effectively targets slower growing ovarian cancer cell lines.